IBDEI2V1 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,45628,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45628,1,3,0)
;;=3^Polymyositis
;;^UTILITY(U,$J,358.3,45628,1,4,0)
;;=4^M33.20
;;^UTILITY(U,$J,358.3,45628,2)
;;=^5011770
;;^UTILITY(U,$J,358.3,45629,0)
;;=R80.9^^172^2273^45
;;^UTILITY(U,$J,358.3,45629,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45629,1,3,0)
;;=3^Proteinuria
;;^UTILITY(U,$J,358.3,45629,1,4,0)
;;=4^R80.9
;;^UTILITY(U,$J,358.3,45629,2)
;;=^5019599
;;^UTILITY(U,$J,358.3,45630,0)
;;=R76.11^^172^2273^41
;;^UTILITY(U,$J,358.3,45630,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45630,1,3,0)
;;=3^Positive PPD
;;^UTILITY(U,$J,358.3,45630,1,4,0)
;;=4^R76.11
;;^UTILITY(U,$J,358.3,45630,2)
;;=^5019570
;;^UTILITY(U,$J,358.3,45631,0)
;;=M35.00^^172^2273^49
;;^UTILITY(U,$J,358.3,45631,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45631,1,3,0)
;;=3^Sjogren Syndrome,Unspec
;;^UTILITY(U,$J,358.3,45631,1,4,0)
;;=4^M35.00
;;^UTILITY(U,$J,358.3,45631,2)
;;=^5011786
;;^UTILITY(U,$J,358.3,45632,0)
;;=B37.0^^172^2273^55
;;^UTILITY(U,$J,358.3,45632,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45632,1,3,0)
;;=3^Thrush
;;^UTILITY(U,$J,358.3,45632,1,4,0)
;;=4^B37.0
;;^UTILITY(U,$J,358.3,45632,2)
;;=Thrush^5000612
;;^UTILITY(U,$J,358.3,45633,0)
;;=I83.91^^172^2274^12
;;^UTILITY(U,$J,358.3,45633,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45633,1,3,0)
;;=3^Varicose Veins,Asymptomatic,Right Lower Extremity
;;^UTILITY(U,$J,358.3,45633,1,4,0)
;;=4^I83.91
;;^UTILITY(U,$J,358.3,45633,2)
;;=^5008020
;;^UTILITY(U,$J,358.3,45634,0)
;;=I83.92^^172^2274^11
;;^UTILITY(U,$J,358.3,45634,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45634,1,3,0)
;;=3^Varicose Veins,Asymptomatic,Left Lower Extremity
;;^UTILITY(U,$J,358.3,45634,1,4,0)
;;=4^I83.92
;;^UTILITY(U,$J,358.3,45634,2)
;;=^5008021
;;^UTILITY(U,$J,358.3,45635,0)
;;=I83.93^^172^2274^10
;;^UTILITY(U,$J,358.3,45635,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45635,1,3,0)
;;=3^Varicose Veins,Asymptomatic,Bilateral Lower Extremities
;;^UTILITY(U,$J,358.3,45635,1,4,0)
;;=4^I83.93
;;^UTILITY(U,$J,358.3,45635,2)
;;=^5008022
;;^UTILITY(U,$J,358.3,45636,0)
;;=I83.019^^172^2274^9
;;^UTILITY(U,$J,358.3,45636,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45636,1,3,0)
;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
;;^UTILITY(U,$J,358.3,45636,1,4,0)
;;=4^I83.019
;;^UTILITY(U,$J,358.3,45636,2)
;;=^5007979
;;^UTILITY(U,$J,358.3,45637,0)
;;=I83.029^^172^2274^8
;;^UTILITY(U,$J,358.3,45637,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45637,1,3,0)
;;=3^Varicose Veins Left Lower Extrem w/ Ulcer Unspec Site
;;^UTILITY(U,$J,358.3,45637,1,4,0)
;;=4^I83.029
;;^UTILITY(U,$J,358.3,45637,2)
;;=^5007986
;;^UTILITY(U,$J,358.3,45638,0)
;;=I71.4^^172^2274^1
;;^UTILITY(U,$J,358.3,45638,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45638,1,3,0)
;;=3^AAA w/o rupture
;;^UTILITY(U,$J,358.3,45638,1,4,0)
;;=4^I71.4
;;^UTILITY(U,$J,358.3,45638,2)
;;=^5007789
;;^UTILITY(U,$J,358.3,45639,0)
;;=I73.9^^172^2274^3
;;^UTILITY(U,$J,358.3,45639,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45639,1,3,0)
;;=3^PVD, unspec
;;^UTILITY(U,$J,358.3,45639,1,4,0)
;;=4^I73.9
;;^UTILITY(U,$J,358.3,45639,2)
;;=^184182
;;^UTILITY(U,$J,358.3,45640,0)
;;=I80.201^^172^2274^4
;;^UTILITY(U,$J,358.3,45640,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45640,1,3,0)
;;=3^Phlebitis & thrombophlebitis deep vessels, right lower extremity
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2V1 3825 printed Sep 23, 2025@20:12:23 Page 2
IBDEI2V1 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,45628,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,45628,1,3,0)
+4 ;;=3^Polymyositis
+5 ;;^UTILITY(U,$J,358.3,45628,1,4,0)
+6 ;;=4^M33.20
+7 ;;^UTILITY(U,$J,358.3,45628,2)
+8 ;;=^5011770
+9 ;;^UTILITY(U,$J,358.3,45629,0)
+10 ;;=R80.9^^172^2273^45
+11 ;;^UTILITY(U,$J,358.3,45629,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,45629,1,3,0)
+14 ;;=3^Proteinuria
+15 ;;^UTILITY(U,$J,358.3,45629,1,4,0)
+16 ;;=4^R80.9
+17 ;;^UTILITY(U,$J,358.3,45629,2)
+18 ;;=^5019599
+19 ;;^UTILITY(U,$J,358.3,45630,0)
+20 ;;=R76.11^^172^2273^41
+21 ;;^UTILITY(U,$J,358.3,45630,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,45630,1,3,0)
+24 ;;=3^Positive PPD
+25 ;;^UTILITY(U,$J,358.3,45630,1,4,0)
+26 ;;=4^R76.11
+27 ;;^UTILITY(U,$J,358.3,45630,2)
+28 ;;=^5019570
+29 ;;^UTILITY(U,$J,358.3,45631,0)
+30 ;;=M35.00^^172^2273^49
+31 ;;^UTILITY(U,$J,358.3,45631,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,45631,1,3,0)
+34 ;;=3^Sjogren Syndrome,Unspec
+35 ;;^UTILITY(U,$J,358.3,45631,1,4,0)
+36 ;;=4^M35.00
+37 ;;^UTILITY(U,$J,358.3,45631,2)
+38 ;;=^5011786
+39 ;;^UTILITY(U,$J,358.3,45632,0)
+40 ;;=B37.0^^172^2273^55
+41 ;;^UTILITY(U,$J,358.3,45632,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,45632,1,3,0)
+44 ;;=3^Thrush
+45 ;;^UTILITY(U,$J,358.3,45632,1,4,0)
+46 ;;=4^B37.0
+47 ;;^UTILITY(U,$J,358.3,45632,2)
+48 ;;=Thrush^5000612
+49 ;;^UTILITY(U,$J,358.3,45633,0)
+50 ;;=I83.91^^172^2274^12
+51 ;;^UTILITY(U,$J,358.3,45633,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,45633,1,3,0)
+54 ;;=3^Varicose Veins,Asymptomatic,Right Lower Extremity
+55 ;;^UTILITY(U,$J,358.3,45633,1,4,0)
+56 ;;=4^I83.91
+57 ;;^UTILITY(U,$J,358.3,45633,2)
+58 ;;=^5008020
+59 ;;^UTILITY(U,$J,358.3,45634,0)
+60 ;;=I83.92^^172^2274^11
+61 ;;^UTILITY(U,$J,358.3,45634,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,45634,1,3,0)
+64 ;;=3^Varicose Veins,Asymptomatic,Left Lower Extremity
+65 ;;^UTILITY(U,$J,358.3,45634,1,4,0)
+66 ;;=4^I83.92
+67 ;;^UTILITY(U,$J,358.3,45634,2)
+68 ;;=^5008021
+69 ;;^UTILITY(U,$J,358.3,45635,0)
+70 ;;=I83.93^^172^2274^10
+71 ;;^UTILITY(U,$J,358.3,45635,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,45635,1,3,0)
+74 ;;=3^Varicose Veins,Asymptomatic,Bilateral Lower Extremities
+75 ;;^UTILITY(U,$J,358.3,45635,1,4,0)
+76 ;;=4^I83.93
+77 ;;^UTILITY(U,$J,358.3,45635,2)
+78 ;;=^5008022
+79 ;;^UTILITY(U,$J,358.3,45636,0)
+80 ;;=I83.019^^172^2274^9
+81 ;;^UTILITY(U,$J,358.3,45636,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,45636,1,3,0)
+84 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
+85 ;;^UTILITY(U,$J,358.3,45636,1,4,0)
+86 ;;=4^I83.019
+87 ;;^UTILITY(U,$J,358.3,45636,2)
+88 ;;=^5007979
+89 ;;^UTILITY(U,$J,358.3,45637,0)
+90 ;;=I83.029^^172^2274^8
+91 ;;^UTILITY(U,$J,358.3,45637,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,45637,1,3,0)
+94 ;;=3^Varicose Veins Left Lower Extrem w/ Ulcer Unspec Site
+95 ;;^UTILITY(U,$J,358.3,45637,1,4,0)
+96 ;;=4^I83.029
+97 ;;^UTILITY(U,$J,358.3,45637,2)
+98 ;;=^5007986
+99 ;;^UTILITY(U,$J,358.3,45638,0)
+100 ;;=I71.4^^172^2274^1
+101 ;;^UTILITY(U,$J,358.3,45638,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,45638,1,3,0)
+104 ;;=3^AAA w/o rupture
+105 ;;^UTILITY(U,$J,358.3,45638,1,4,0)
+106 ;;=4^I71.4
+107 ;;^UTILITY(U,$J,358.3,45638,2)
+108 ;;=^5007789
+109 ;;^UTILITY(U,$J,358.3,45639,0)
+110 ;;=I73.9^^172^2274^3
+111 ;;^UTILITY(U,$J,358.3,45639,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,45639,1,3,0)
+114 ;;=3^PVD, unspec
+115 ;;^UTILITY(U,$J,358.3,45639,1,4,0)
+116 ;;=4^I73.9
+117 ;;^UTILITY(U,$J,358.3,45639,2)
+118 ;;=^184182
+119 ;;^UTILITY(U,$J,358.3,45640,0)
+120 ;;=I80.201^^172^2274^4
+121 ;;^UTILITY(U,$J,358.3,45640,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,45640,1,3,0)
+124 ;;=3^Phlebitis & thrombophlebitis deep vessels, right lower extremity
